Target intelligence / Profile preview

Ribosomal protein L23a pseudogene 59 (RPL23AP59)

Target
RPL23AP59
Molecular classification
Other (Processed pseudogene)
01

Overview

Ribosomal protein L23a pseudogene 59 (RPL23AP59) is a processed pseudogene of the human RPL23A gene, which encodes a component of the 60S large ribosomal subunit. Pseudogenes like RPL23AP59 do not produce functional proteins and typically lack biological activity. While the parental gene RPL23A plays a structural role in protein synthesis as part of the ribosome, and some RPL23A pseudogenes have been studied for altered expression in cancer, there is no current evidence that RPL23AP59 itself is functionally relevant, disease-associated, or a therapeutic target. RPL23AP59 is a non-functional pseudogene with no established role as a drug target or biomarker. Its sequence similarity to RPL23A explains its classification, but it does not encode a protein and is not cataloged as relevant for therapeutic intervention or as a point of pharmacological action.

02

Mechanism of action

None (No known drugs affect this pseudogene; mechanisms are not applicable)

03

Biological functions

Other (No known direct biological function; pseudogenes typically do not encode functional proteins)
04

Disease associations

Other (No direct disease association or functional role documented for RPL23AP59)

Beyond the preview

Go deeper on Ribosomal protein L23a pseudogene 59 (RPL23AP59).

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Drug pipeline

Full profile access

Explore the programs pursuing this target and their development progress.

  • Drug candidates
  • Developers
  • Development stage

Clinical trials

Full profile access

Follow the clinical studies evaluating therapies directed at this target.

  • Trial design
  • Status
  • Readouts

Competitive landscape

Full profile access

Compare approaches across drug candidates, modalities, and indications.

  • Programs
  • Modalities
  • Indications

Literature & evidence

Full profile access

Investigate the research and source evidence behind target biology and development.

  • Publications
  • Sources
  • Analysis

Patents

Full profile access

Explore patent activity around therapies and technologies addressing this target.

  • Patents
  • Assignees
  • Technologies

Research & analysis

Full profile access

Connect target biology, drug development, and emerging evidence in your research.

  • Biology
  • Development news
  • Analysis

Bring the full picture into focus.

See how Gosset can support your research on Ribosomal protein L23a pseudogene 59 (RPL23AP59).

Explore the full profile

Gosset Free

Get started with Gosset.

Enter your work email and we’ll be in touch with next steps.

Work email preferred.

Book a call